| Literature DB >> 35669576 |
Yuhan Jiang1,2,3, Ming Qi4, Jinpeng Zhang5, Yuanlin Wen1,2,3, Jiamin Sun1,2,3, Qigen Liu1,2,3.
Abstract
The Qingtian paddy field carp (Cyprinus carpio var qingtianensis) is a local carp cultivated in the rice field of Qingtian county, Zhejiang province, China. The paddy field environment is distinct from the pond environment. Due to the inability to artificially increase oxygen, the dissolved oxygen greatly changes during the day. Therefore, investigating the physiological regulation to the changes of acute dissolved oxygen in Qingtian paddy field carp (PF-carp) will dramatically clarify how it adapts to the paddy breeding environment. The high tolerance of Qingtian paddy field carp to hypoxia makes it an ideal organism for studying molecular regulatory mechanisms during hypoxia process and reoxygenation following hypoxia in fish. In this study, we compared the changes of metabolites in the hepatopancreas during hypoxia stress and the following reoxygenation through comparative metabolomics. The results showed 131 differentially expressed metabolites between the hypoxic groups and control groups. Among them, 95 were up-regulated, and 36 were down-regulated. KEGG Pathway enrichment analysis showed that these differential metabolites were mainly involved in regulating lipid, protein, and purine metabolism PF-carps could require energy during hypoxia by enhancing the gluconeogenesis pathway with core glutamic acid and glutamine metabolism. A total of 63 differentially expressed metabolites were screened by a comparison between the reoxygenated groups and the hypoxic groups. Specifically, 15 were up-regulated, and 48 were down-regulated. The KEGG Pathway enrichment analysis supported that PF-carp could continue to gain energy by consuming glutamic acid and the glutamine accumulated during hypoxia and simultaneously weaken the ammonia-transferring effect of amino acids and the toxicity of ammonia. By consuming glycerophospholipids and maintaining the Prostaglandin E content, cell damage was improved, sphingosinol synthesis was reduced, and apoptosis was inhibited. Additionally, it could enhance the salvage synthesis and de novo synthesis of purine, reduce purine accumulation, promote the synthesis of nucleotide and energy carriers, and assist in recovering physiological metabolism. Overall, results explained the physiological regulation mechanism of PF-carp adapting to the acute changes of dissolved oxygen at the metabolic level and also provided novel evidence for physiological regulation of other fish in an environment with acute changes in dissolved oxygen levels.Entities:
Keywords: carp Cyprinus carpio var qingtianensis; hepatopancreas; hypoxia; metabolomics; reoxygenation
Year: 2022 PMID: 35669576 PMCID: PMC9163826 DOI: 10.3389/fphys.2022.853850
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Total ion flow (TIC) of the samples of hepatopancreas of Cyprinus carpio var. qingtianensis were obtained in the modes of positive (ESI+) and negative (ESI-). Note: (A): ESI + mode; (B): ESI - mode; CH1-CH6: normoxic group with 6 samples; HH1-HH6:6 samples from the experimental group under hypoxic stress for 6 h; RH1-RH6: Reoxygenation recovery with 6 h experiment and 6 samples; QC1-QC4: Quality control with 4 samples.
FIGURE 2PCA score plot of samples in treatment groups and QC (ESI+, ESI−).
FIGURE 3OPLS-DA score scatter plot in HH vs. CH, RH vs. HH and RH vs. CH groups (ESI+, ESI−) (A): HH vs. CH (ESI+); (B): HH vs. CH (ESI−); (C): RH vs. HH (ESI+); (D): RH vs. HH (ESI−); (E): RH vs. CH (ESI+); (F): RH vs. CH (ESI−).
FIGURE 4Statistics for metabolites of differential expression among the three comparative groups. Note: (A): Overview of different metabolites between two comparison groups; (B): The volcanic figure of differential expressed metabolites in HH vs. CH groups; (C): The volcanic figure of differential expressed metabolites in RH vs. HH groups; (D): The volcanic figure of differential expressed metabolites in RH vs. CH groups.
Significantly different metabolites.
| Metabolic pathway ((KEGG Pathway) | Metabolite | ESI+/− | Rt (min) |
| VIP Value |
| Up/Down-regulated | ||
|---|---|---|---|---|---|---|---|---|---|
| HH | RH | RH | |||||||
| Carbohydrate metabolism | Oxoglutaric acid | ESI
| 0.8218 | 191.02 | 1.07 | 0.017 | ↑ | — | — |
| Glyceraldehyde-3-phosphate | ESI
| 8.17 | 168.99 | 1.05 | 0.042 | ↑ | — | — | |
| Amino acid metabolism | Glutamate | ESI+ | 0.48 | 148.06 | 1.81 | 0.027 | ↑ | ↓ | — |
| Glutamine | ESI
| 2.79 | 145.06 | 2.70 | 0.010 | — | ↓ | ↓ | |
| N-Acetyl-L-glutamic acid | ESI
| 0.85 | 188.06 | 2.75 | 0.035 | — | — | ↓ | |
| Ornithine | ESI+ | 1.67 | 174.12 | 1.17 | 0.042 | — | ↓ | — | |
| Lipid metabolism | PC (14:1(9Z)/20:2(11Z,14Z)) | ESI+ | 10.55 | 756.55 | 1.29 | 0.050 | ↑ | — | — |
| PC (16:1(9Z)/16:1(9Z)) | ESI+ | 1.94 | 730.54 | 1.72 | 0.003 | ↑ | — | — | |
| PE (14:0/22:4(7Z,10Z,13Z,16Z)) | ESI+ | 0.54 | 781.55 | 1.33 | 0.030 | ↑ | — | — | |
| PE (20:3(5Z,8Z,11Z)/18:1(11Z)) | ESI
| 3.20 | 812.54 | 2.89 | 0.000 | ↑ | — | ↑ | |
| PS (18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ESI+ | 11.21 | 836.54 | 1.58 | 0.012 | ↑ | — | — | |
| LysoPC (15:0) | ESI+ | 7.67 | 482.32 | 1.27 | 0.017 | ↓ | — | — | |
| LysoPC (20:2(11Z,14Z)) | ESI+ | 7.16 | 548.37 | 1.73 | 0.031 | ↑ | — | — | |
| LysoPC (22:4(7Z,10Z,13Z,16Z)) | ESI+ | 10.80 | 572.37 | 1.75 | 0.005 | ↓ | ↑ | — | |
| PGE-Prostaglandin | ESI+ | 7.31 | 367.28 | 2.11 | 0.032 | ↑ | — | — | |
| SM (d18:1/16:0) | ESI+ | 1.47 | 703.57 | 1.54 | 0.039 | ↑ | — | — | |
| Sphingosine | ESI+ | 10.89 | 300.29 | 1.42 | 0.013 | ↓ | ↑ | — | |
| Purine metabolism | Guanosine | ESI+ | 3.59 | 284.10 | 2.80 | 0.001 | ↑ | ↓ | — |
| Guanine | ESI+ | 0.84 | 152.06 | 1.06 | 0.016 | ↑ | ↓ | — | |
| Xanthine | ESI+ | 7.58 | 153.04 | 1.02 | 0.031 | ↓ | — | — | |
| Glutamate | ESI+ | 0.48 | 148.06 | 1.81 | 0.027 | ↑ | ↓ | — | |
Note: a: PC—Phosphatidylcholine, PE—Phosphatidylethanolamine, LysoPC—Lyso phosphatidylcholine, SM—Phingomyelin; b: Variable importance in the Projection (VIP) is obtained from the OPLS-DA, model. These discriminating metabolites were obtained using a statistically significant threshold of variable influence on projection (VIP >1.0). c: p value obtained from analysis of variance (ANOVA). Setting the screening threshold to p-value < 0.05. p-value = 0.000 means p-value is less than 0.001; d: “↑” indicates a significant increase, “↓” indicates a significant reduction, “—” indicates no significant difference.
FIGURE 5(A): Enrichment of metabolic pathways of DEMs in HH vs. CH groups (KEGG Topology Analysis). Note: a: D-Glutamine and D-glutamate metabolism; b: Glycerophospholipid metabolism; c: Steroid hormone biosynthesis; d: Sphingolipid metabolism; e: Purine metabolism; f: Alanine, aspartate and glutamate metabolism; g: Pentose and glucuronate interconversions; h: Glutathione metabolism; i: Linoleic acid metabolism; j: Arachidonic acid metabolism. (B): Enrichment of metabolic pathways of DEMs in RH vs. HH groups (KEGG Topology Analysis). Note: a: D-Glutamine and D-glutamate metabolism; b: D-Arginine and D-ornithine metabolism; c: Alanine, aspartate and glutamate metabolism; d: Arginine metabolism; e: Glutathione metabolism; f: Aminoacyl-tRNA biosynthesis; g: beta-Alanine metabolism; h: Glyoxylate and dicarboxylate metabolism; i: Taurine and hypotaurine metabolism; j: Pentose and glucuronate interconversions. (C): Enrichment of metabolic pathways of DEMs in RH vs. CH groups (KEGG Topology Analysis). Note: a: Lysine degradation; b: Glycerophospholipid metabolism; c: Alanine, aspartate and glutamate metabolism; d: Aminoacyl-tRNA biosynthesis; e: D-D-Glutamine and D-glutamate metabolism; f: Valine, leucine and isoleucine biosynthesis; g: Pantothenate and CoA biosynthesis; h: Glutathione metabolism; i: Glycine, serine and threonine metabolism; j: Pyrimidine metabolism.
FIGURE 6The main metabolites and their related KEGG pathways.